Canagliflozin and Myocardial Fibrosis

Clinical trial NCT05367063 · COMPLETED

Trial details

NCT number: NCT05367063
Sponsor: Shanghai Zhongshan Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Cardiovascular Risk

Start date: 2022-01-05
Primary completion: 2024-12-31
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.